<--- Back to Details
First PageDocument Content
Cervarix / Gardasil / HPV vaccine / Human papillomavirus / Center for Biologics Evaluation and Research / Anal cancer / Vaginal intraepithelial neoplasia / Wart / Vulvar intraepithelial neoplasia / Papillomavirus / Medicine / Vaccines
Cervarix
Gardasil
HPV vaccine
Human papillomavirus
Center for Biologics Evaluation and Research
Anal cancer
Vaginal intraepithelial neoplasia
Wart
Vulvar intraepithelial neoplasia
Papillomavirus
Medicine
Vaccines

MID-CYCLE MEETING SUMMARY

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 270,97 KB

Share Document on Facebook

Similar Documents

Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA Staff

Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA Staff

DocID: 1ogsZ - View Document

Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docx

Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docx

DocID: 1gkCa - View Document

   Global	
  Healthy	
  Living	
  Foundation	
   515	
  North	
  Midland	
  Avenue	
   Upper	
  Nyack,	
  New	
  York	
  10960	
  USA	
   +1	
  845	
  348	
  0400	
  

  Global  Healthy  Living  Foundation   515  North  Midland  Avenue   Upper  Nyack,  New  York  10960  USA   +1  845  348  0400  

DocID: 1g1KY - View Document

Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications

Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications

DocID: 1fuJJ - View Document

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry

DocID: 1aZ0Q - View Document